Status:
COMPLETED
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
Lead Sponsor:
Eli Lilly and Company
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
FEMALE
50-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the effect of arzoxifene to raloxifene on the bone mineral density (bone strength).
Eligibility Criteria
Inclusion
- Must have osteoporosis
- Must be between 50 and 75 years old and be able to walk
- Have at least two of your back bones that can be x-rayed
- Have not had a period in at least two years
- Be willing to have blood tests
Exclusion
- Have a bone disease other than osteoporosis
- History of estrogen dependent cancer
- History of stroke or certain heart problems
- Possibly have an allergy to raloxifene or arzoxifene
- Have certain abnormal lab values
- History of seizure disorder
- Have unexplained vaginal bleeding or an abnormal pap smear
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00383422
Start Date
October 1 2006
End Date
July 1 2008
Last Update
January 28 2010
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Gainesville, Georgia, United States, 30501
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Urbandale, Iowa, United States, 50322
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Billings, Montana, United States, 59101
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Cincinnati, Ohio, United States, 45224